01.06.2013 Views

Statistical Methods in Medical Research 4ed

Statistical Methods in Medical Research 4ed

Statistical Methods in Medical Research 4ed

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

labelled antigen so that the count is low. The dose±response curve is typically<br />

sigmoid <strong>in</strong> shape, with an upper asymptote, D, to the mean response, at zero<br />

dose, and a lower asymptote, C, at very high doses. If the mean bound count at<br />

log dose x is U, the quantity<br />

U C<br />

Y ˆ ln …20:10†<br />

D U<br />

is analogous to the logit transformation for proportions (14.5) and it is often<br />

(though not always) found that Y is approximately l<strong>in</strong>early related to x.<br />

In an immunoradiometric assay (IRMA) the roles of antigen and antibody are<br />

<strong>in</strong>terchanged, but the pr<strong>in</strong>ciples are otherwise the same as for RIAs.<br />

RIAs are used rout<strong>in</strong>ely <strong>in</strong> cl<strong>in</strong>ical chemistry, and specimens from many<br />

different patients may be assayed aga<strong>in</strong>st the same standard. The precision of<br />

RIAs is relatively high, and it is common for responses to be made at a s<strong>in</strong>gle<br />

dose of each test preparation, for comparison with a standard curve determ<strong>in</strong>ed<br />

from read<strong>in</strong>gs at several doses. This design may achieve potency estimates of<br />

adequate precision, but it permits no test of parallelism, and should only be used<br />

if the assay validity has already been established by a larger design.<br />

Although potencies are often estimated by eye, a formal approach, provid<strong>in</strong>g<br />

estimates of error and validity tests, is preferable. F<strong>in</strong>ney (1978) gives details of<br />

such an approach, and the author also (F<strong>in</strong>ney, 1979) describes the desiderata<br />

for computer programs <strong>in</strong>tended for the rout<strong>in</strong>e analysis of RIAs. See also<br />

Gov<strong>in</strong>darajulu (2000). The statistical methodology is a direct extension of that<br />

described earlier <strong>in</strong> this section, with some additional features. In particular: (i) the<br />

lower and upper asymptotes, C and D, need to be estimated from the data (counts<br />

will usually have been observed at each of the extremes of dose level); and (ii) the<br />

variance of the observed count u is likely to <strong>in</strong>crease with the mean U. Ideally, u<br />

might be expected to follow a Poisson distribution, but there is often some<br />

additional source of variation, caus<strong>in</strong>g the variance to be greater than the mean.<br />

A full analysis may assume a normal approximation, but the need to estimate the<br />

asymptotes and to take account of the logit transformation (20.10) leads to an<br />

iterative least squares or maximum likelihood solution, as <strong>in</strong> §12.4. The relationship<br />

of var(u)toUmay be estimated as part of the solution, or it may be possible to<br />

assume some functional relationship on the basis of past experience.<br />

Comb<strong>in</strong>ation of assays<br />

20.2 Parallel-l<strong>in</strong>e assays 723<br />

Assays to determ<strong>in</strong>e the relative potency of a particular (S, T) pair may<br />

be replicated, as <strong>in</strong> other scientific experiments, to improve precision and<br />

extend the validity of the results. More specifically, T may be <strong>in</strong>tended as a<br />

future standard preparation, and collaborative studies to compare T with the<br />

previous standard S may <strong>in</strong>volve many different laboratories.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!